Editorial · Independent · Methodology published
In-depth reviews of every major GLP-1 telehealth provider. Full 12-month cost breakdowns, head-to-head comparisons, and a published ranking methodology. Rankings are editorial — not for sale.
Scored on price, clinical oversight, transparency, and support. See our methodology.
The category's biggest consumer brand, now with FDA-approved Wegovy
Flat $179/month — traded its aggressive-intro model for predictable mid-tier pricing
The insurance-navigation play — helps members route to covered Wegovy/Zepbound
Editorial methodology published. Commission rates are not a scoring input. Partners we've declined — or that declined us — are still included in our comparisons.
Every provider page shows a 'last verified' date. Pricing and regulatory status are crawled weekly and reviewed against FDA and FTC sources.
We decline partnerships with providers that use AI-generated clinicians, stolen testimonials, or fabricated user stories. That list is public.
Mechanism, satiety signaling, and what the research actually shows.
Explore CompareHims vs Ro, Ro vs Henry Meds, and every major permutation.
Explore CostWhat providers actually cost once the intro rate expires.
Explore ProvidersFull reviews with pricing, process, clinical oversight, and verdict.
Explore